Delisting risk
Theriva Biologics
Develops stroma-degrading oncolytic viruses for difficult-to-treat solid tumors.
$0.2500
After-hours close+0.01 (+2.17%)
At close$0.2447(−3.09%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.07 | — | — |
| Aug 2026 | −$0.06 | −$0.07 | −27.3% |
| Aug 2026 | −$0.06 | −$0.07 | −27.3% |
| May 2026 | −$0.05 | −$0.05 | 0.0% |
| Mar 2026 | −$0.44 | $1.85 | +525.3% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Nov 2025 | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 17, 2026 | −$0.07 | — | — | — | — | — |
| Aug 12, 2026 | −$0.06 | −$0.07 | −27.3% | $300.0K | — | — |
| Aug 11, 2026 | −$0.06 | −$0.07 | −27.3% | — | — | — |
| May 5, 2026 | −$0.05 | −$0.05 | 0.0% | $300.0K | $300.0K | 0.0% |
| Mar 12, 2026 | −$0.44 | $1.85 | +525.3% | — | — | — |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Nov 12, 2025 | ||||||
| Aug 11, 2025 | ||||||
| May 14, 2025 | ||||||
| Mar 6, 2025 | ||||||
| Nov 12, 2024 | ||||||
| Aug 13, 2024 | ||||||
| May 7, 2024 | ||||||
| Mar 25, 2024 | ||||||
| Nov 13, 2023 | ||||||
| Aug 8, 2023 | ||||||
| May 11, 2023 | ||||||
| Mar 30, 2023 | ||||||
| Nov 10, 2022 | ||||||
| Aug 11, 2022 | ||||||
| May 16, 2022 | ||||||
| Mar 16, 2022 | ||||||
| Nov 3, 2021 | ||||||
| Aug 5, 2021 | ||||||
| May 5, 2021 | ||||||
| Mar 4, 2021 | ||||||
| Nov 10, 2020 | ||||||
| Aug 6, 2020 | ||||||
| May 5, 2020 | ||||||
| Feb 20, 2020 | ||||||
| Nov 4, 2019 | ||||||
| Aug 8, 2019 | ||||||
| May 8, 2019 | ||||||
| Feb 27, 2019 | ||||||
| Nov 8, 2018 | ||||||
| Aug 8, 2018 | ||||||
| May 8, 2018 | ||||||
| Feb 22, 2018 | ||||||
| Nov 1, 2017 | ||||||
| Aug 3, 2017 | ||||||
| May 4, 2017 | ||||||
| Mar 2, 2017 | ||||||
| Nov 1, 2016 | ||||||
| Aug 3, 2016 | ||||||
| May 5, 2016 | ||||||
| Mar 10, 2016 | ||||||
| Nov 5, 2015 | ||||||